Biotech Stories http://www.fiercebiotech.com/rss/xml en Cell Medica, UCL team up on modified T cell receptor cancer meds http://www.fiercebiotech.com/biotech/cell-medica-ucl-team-up-modified-t-cell-receptor-cancer-meds <span property="schema:name">Cell Medica, UCL team up on modified T cell receptor cancer meds</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-24T10:05:15+00:00">Wed, 08/24/2016 - 06:05</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/cell-medica-ucl-team-up-modified-t-cell-receptor-cancer-meds" data-a2a-title="Cell Medica, UCL team up on modified T cell receptor cancer meds"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fcell-medica-ucl-team-up-modified-t-cell-receptor-cancer-meds&amp;title=Cell%20Medica%2C%20UCL%20team%20up%20on%20modified%20T%20cell%20receptor%20cancer%20meds"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Wed, 24 Aug 2016 10:05:15 +0000 badams 456821 at http://www.fiercebiotech.com Promethera plans IPO to bankroll pipeline of liver disease cell therapies http://www.fiercebiotech.com/biotech/promethera-plans-ipo-to-bankroll-pipeline-liver-disease-cell-therapies <span property="schema:name">Promethera plans IPO to bankroll pipeline of liver disease cell therapies</span> <span rel="schema:author"><span lang="" about="/user/39341" typeof="schema:Person" property="schema:name" datatype="">ntaylor</span></span> <span property="schema:dateCreated" content="2016-08-24T09:54:16+00:00">Wed, 08/24/2016 - 05:54</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/promethera-plans-ipo-to-bankroll-pipeline-liver-disease-cell-therapies" data-a2a-title="Promethera plans IPO to bankroll pipeline of liver disease cell therapies"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpromethera-plans-ipo-to-bankroll-pipeline-liver-disease-cell-therapies&amp;title=Promethera%20plans%20IPO%20to%20bankroll%20pipeline%20of%20liver%20disease%20cell%20therapies"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Wed, 24 Aug 2016 09:54:16 +0000 ntaylor 456811 at http://www.fiercebiotech.com It didn’t get the whole package, but Pfizer will pay $1.5B for AZ’s antibiotics biz http://www.fiercebiotech.com/biotech/it-didn-t-get-whole-package-but-pfizer-will-pay-1-5b-for-az-s-antibiotics-biz <span property="schema:name">It didn’t get the whole package, but Pfizer will pay $1.5B for AZ’s antibiotics biz</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-24T07:54:57+00:00">Wed, 08/24/2016 - 03:54</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/it-didn-t-get-whole-package-but-pfizer-will-pay-1-5b-for-az-s-antibiotics-biz" data-a2a-title="It didn’t get the whole package, but Pfizer will pay $1.5B for AZ’s antibiotics biz"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fit-didn-t-get-whole-package-but-pfizer-will-pay-1-5b-for-az-s-antibiotics-biz&amp;title=It%20didn%E2%80%99t%20get%20the%20whole%20package%2C%20but%20Pfizer%20will%20pay%20%241.5B%20for%20AZ%E2%80%99s%20antibiotics%20biz"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Wed, 24 Aug 2016 07:54:57 +0000 badams 456801 at http://www.fiercebiotech.com Wall Street looks for Clovis to make good in ovarian cancer, after lung cancer failure http://www.fiercebiotech.com/biotech/wall-street-looks-for-clovis-to-make-good-ovarian-cancer-after-lung-cancer-failure <span property="schema:name">Wall Street looks for Clovis to make good in ovarian cancer, after lung cancer failure</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-23T19:56:30+00:00">Tue, 08/23/2016 - 15:56</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/wall-street-looks-for-clovis-to-make-good-ovarian-cancer-after-lung-cancer-failure" data-a2a-title="Wall Street looks for Clovis to make good in ovarian cancer, after lung cancer failure"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fwall-street-looks-for-clovis-to-make-good-ovarian-cancer-after-lung-cancer-failure&amp;title=Wall%20Street%20looks%20for%20Clovis%20to%20make%20good%20in%20ovarian%20cancer%2C%20after%20lung%20cancer%20failure"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 19:56:30 +0000 slawrence 456761 at http://www.fiercebiotech.com Novartis licenses its anti-PCSK9 to sepsis startup Cyon http://www.fiercebiotech.com/biotech/novartis-licenses-its-anti-pcsk9-to-sepsis-startup-cyon <span property="schema:name">Novartis licenses its anti-PCSK9 to sepsis startup Cyon</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-23T17:00:00+00:00">Tue, 08/23/2016 - 13:00</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/novartis-licenses-its-anti-pcsk9-to-sepsis-startup-cyon" data-a2a-title="Novartis licenses its anti-PCSK9 to sepsis startup Cyon"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fnovartis-licenses-its-anti-pcsk9-to-sepsis-startup-cyon&amp;title=Novartis%20licenses%20its%20anti-PCSK9%20to%20sepsis%20startup%20Cyon"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 17:00:00 +0000 slawrence 456741 at http://www.fiercebiotech.com Regenerative player BioCardia reverse merges to back PhIII in heart failure http://www.fiercebiotech.com/biotech/regenerative-player-biocardia-reverse-merges-to-back-phase-iii-heart-failure <span property="schema:name">Regenerative player BioCardia reverse merges to back PhIII in heart failure</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-23T14:55:18+00:00">Tue, 08/23/2016 - 10:55</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/regenerative-player-biocardia-reverse-merges-to-back-phase-iii-heart-failure" data-a2a-title="Regenerative player BioCardia reverse merges to back PhIII in heart failure"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fregenerative-player-biocardia-reverse-merges-to-back-phase-iii-heart-failure&amp;title=Regenerative%20player%20BioCardia%20reverse%20merges%20to%20back%20PhIII%20in%20heart%20failure"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 14:55:18 +0000 slawrence 456706 at http://www.fiercebiotech.com Gilead, Galapagos start PhIII of RA drug, 8 months after AbbVie began rival program http://www.fiercebiotech.com/biotech/gilead-galapagos-start-phiii-ra-drug-8-months-after-abbvie-began-rival-program <span property="schema:name">Gilead, Galapagos start PhIII of RA drug, 8 months after AbbVie began rival program </span> <span rel="schema:author"><span lang="" about="/user/39341" typeof="schema:Person" property="schema:name" datatype="">ntaylor</span></span> <span property="schema:dateCreated" content="2016-08-23T10:50:35+00:00">Tue, 08/23/2016 - 06:50</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/gilead-galapagos-start-phiii-ra-drug-8-months-after-abbvie-began-rival-program" data-a2a-title="Gilead, Galapagos start PhIII of RA drug, 8 months after AbbVie began rival program "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fgilead-galapagos-start-phiii-ra-drug-8-months-after-abbvie-began-rival-program&amp;title=Gilead%2C%20Galapagos%20start%20PhIII%20of%20RA%20drug%2C%208%20months%20after%20AbbVie%20began%20rival%20program%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 10:50:35 +0000 ntaylor 456651 at http://www.fiercebiotech.com PhIII failure, 60% of staffers axed; now Tokai has some more bad news http://www.fiercebiotech.com/biotech/phiii-failure-60-staffers-axed-now-tokai-has-some-more-bad-news <span property="schema:name">PhIII failure, 60% of staffers axed; now Tokai has some more bad news</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-23T10:29:24+00:00">Tue, 08/23/2016 - 06:29</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/phiii-failure-60-staffers-axed-now-tokai-has-some-more-bad-news" data-a2a-title="PhIII failure, 60% of staffers axed; now Tokai has some more bad news"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fphiii-failure-60-staffers-axed-now-tokai-has-some-more-bad-news&amp;title=PhIII%20failure%2C%2060%25%20of%20staffers%20axed%3B%20now%20Tokai%20has%20some%20more%20bad%20news"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 10:29:24 +0000 badams 456641 at http://www.fiercebiotech.com All bets are on for biotech deals after $14B Medivation bonanza http://www.fiercebiotech.com/biotech/all-bets-are-for-biotech-deals-after-14b-medivation-bonanza <span property="schema:name">All bets are on for biotech deals after $14B Medivation bonanza </span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-23T08:08:36+00:00">Tue, 08/23/2016 - 04:08</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/all-bets-are-for-biotech-deals-after-14b-medivation-bonanza" data-a2a-title="All bets are on for biotech deals after $14B Medivation bonanza "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fall-bets-are-for-biotech-deals-after-14b-medivation-bonanza&amp;title=All%20bets%20are%20on%20for%20biotech%20deals%20after%20%2414B%20Medivation%20bonanza%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Tue, 23 Aug 2016 08:08:36 +0000 badams 456631 at http://www.fiercebiotech.com Crossover investor backs antibiotic-resistant dermatology startup into the clinic http://www.fiercebiotech.com/biotech/crossover-investor-backs-antibiotic-resistant-dermatology-startup-into-clinic <span property="schema:name">Crossover investor backs antibiotic-resistant dermatology startup into the clinic</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-22T22:48:42+00:00">Mon, 08/22/2016 - 18:48</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/crossover-investor-backs-antibiotic-resistant-dermatology-startup-into-clinic" data-a2a-title="Crossover investor backs antibiotic-resistant dermatology startup into the clinic"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fcrossover-investor-backs-antibiotic-resistant-dermatology-startup-into-clinic&amp;title=Crossover%20investor%20backs%20antibiotic-resistant%20dermatology%20startup%20into%20the%20clinic"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 22:48:42 +0000 slawrence 456611 at http://www.fiercebiotech.com Langer’s PixarBio reverse merging, raising $30M to replace opioids http://www.fiercebiotech.com/langar-s-pixarbio-reverse-merging-raising-30m-to-replace-opioids <span property="schema:name">Langer’s PixarBio reverse merging, raising $30M to replace opioids</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-22T20:18:55+00:00">Mon, 08/22/2016 - 16:18</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/langar-s-pixarbio-reverse-merging-raising-30m-to-replace-opioids" data-a2a-title="Langer’s PixarBio reverse merging, raising $30M to replace opioids"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Flangar-s-pixarbio-reverse-merging-raising-30m-to-replace-opioids&amp;title=Langer%E2%80%99s%20PixarBio%20reverse%20merging%2C%20raising%20%2430M%20to%20replace%20opioids"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 20:18:55 +0000 slawrence 456601 at http://www.fiercebiotech.com Regeneron, BARDA partner to develop MERS virus treatment http://www.fiercebiotech.com/biotech/regeneron-barda-partner-to-develop-mers-virus-treatment <span property="schema:name">Regeneron, BARDA partner to develop MERS virus treatment</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-22T14:50:30+00:00">Mon, 08/22/2016 - 10:50</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/regeneron-barda-partner-to-develop-mers-virus-treatment" data-a2a-title="Regeneron, BARDA partner to develop MERS virus treatment"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fregeneron-barda-partner-to-develop-mers-virus-treatment&amp;title=Regeneron%2C%20BARDA%20partner%20to%20develop%20MERS%20virus%20treatment"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 14:50:30 +0000 slawrence 456521 at http://www.fiercebiotech.com Lilly, AstraZeneca nab fast-track review for BACE inhibitor in Alzheimer’s http://www.fiercebiotech.com/biotech/lilly-astrazeneca-nab-fast-track-review-for-bace-inhibitor-azheimer-s <span property="schema:name">Lilly, AstraZeneca nab fast-track review for BACE inhibitor in Alzheimer’s</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-22T14:11:05+00:00">Mon, 08/22/2016 - 10:11</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/lilly-astrazeneca-nab-fast-track-review-for-bace-inhibitor-azheimer-s" data-a2a-title="Lilly, AstraZeneca nab fast-track review for BACE inhibitor in Alzheimer’s"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Flilly-astrazeneca-nab-fast-track-review-for-bace-inhibitor-azheimer-s&amp;title=Lilly%2C%20AstraZeneca%20nab%20fast-track%20review%20for%20BACE%20inhibitor%20in%20Alzheimer%E2%80%99s"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 14:11:05 +0000 slawrence 456511 at http://www.fiercebiotech.com DS Biopharma spins out biotech to focus on NASH, fibrotic candidates http://www.fiercebiotech.com/biotech/ds-biopharma-spins-out-biotech-to-focus-nash-fibrotic-candidates <span property="schema:name">DS Biopharma spins out biotech to focus on NASH, fibrotic candidates</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-22T10:04:08+00:00">Mon, 08/22/2016 - 06:04</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/ds-biopharma-spins-out-biotech-to-focus-nash-fibrotic-candidates" data-a2a-title="DS Biopharma spins out biotech to focus on NASH, fibrotic candidates"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fds-biopharma-spins-out-biotech-to-focus-nash-fibrotic-candidates&amp;title=DS%20Biopharma%20spins%20out%20biotech%20to%20focus%20on%20NASH%2C%20fibrotic%20candidates"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 10:04:08 +0000 badams 456451 at http://www.fiercebiotech.com Oral pain biotech Thar Pharmaceuticals files for $50M public offering http://www.fiercebiotech.com/biotech/oral-pain-biotech-thar-pharmaceuticals-files-for-50m-public-offering <span property="schema:name">Oral pain biotech Thar Pharmaceuticals files for $50M public offering </span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-22T08:27:06+00:00">Mon, 08/22/2016 - 04:27</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/oral-pain-biotech-thar-pharmaceuticals-files-for-50m-public-offering" data-a2a-title="Oral pain biotech Thar Pharmaceuticals files for $50M public offering "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Foral-pain-biotech-thar-pharmaceuticals-files-for-50m-public-offering&amp;title=Oral%20pain%20biotech%20Thar%20Pharmaceuticals%20files%20for%20%2450M%20public%20offering%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 08:27:06 +0000 badams 456416 at http://www.fiercebiotech.com UPDATED: Pfizer buys Medivation for $81.50 a share http://www.fiercebiotech.com/biotech/medivation-could-accept-14b-pfizer-bid-week-ft <span property="schema:name">UPDATED: Pfizer buys Medivation for $81.50 a share</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-22T07:34:32+00:00">Mon, 08/22/2016 - 03:34</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/medivation-could-accept-14b-pfizer-bid-week-ft" data-a2a-title="UPDATED: Pfizer buys Medivation for $81.50 a share"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fmedivation-could-accept-14b-pfizer-bid-week-ft&amp;title=UPDATED%3A%20Pfizer%20buys%20Medivation%20for%20%2481.50%20a%20share"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Mon, 22 Aug 2016 07:34:32 +0000 badams 456406 at http://www.fiercebiotech.com FDA delays decision on Sanofi, Zealand’s diabetes drug, handing lead to Novo Nordisk http://www.fiercebiotech.com/biotech/fda-delays-decision-sanofi-zealand-s-diabetes-drug-handing-lead-to-novo-nordisk <span property="schema:name">FDA delays decision on Sanofi, Zealand’s diabetes drug, handing lead to Novo Nordisk </span> <span rel="schema:author"><span lang="" about="/user/39341" typeof="schema:Person" property="schema:name" datatype="">ntaylor</span></span> <span property="schema:dateCreated" content="2016-08-21T09:06:06+00:00">Sun, 08/21/2016 - 05:06</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/fda-delays-decision-sanofi-zealand-s-diabetes-drug-handing-lead-to-novo-nordisk" data-a2a-title="FDA delays decision on Sanofi, Zealand’s diabetes drug, handing lead to Novo Nordisk "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Ffda-delays-decision-sanofi-zealand-s-diabetes-drug-handing-lead-to-novo-nordisk&amp;title=FDA%20delays%20decision%20on%20Sanofi%2C%20Zealand%E2%80%99s%20diabetes%20drug%2C%20handing%20lead%20to%20Novo%20Nordisk%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Sun, 21 Aug 2016 09:06:06 +0000 ntaylor 456396 at http://www.fiercebiotech.com Bayer, CRISPR Therapeutics JV to start at Kendall Square location http://www.fiercebiotech.com/biotech/kendall-square-location-choice-for-bayer-and-crispr-therapeutics-upstart <span property="schema:name">Bayer, CRISPR Therapeutics JV to start at Kendall Square location </span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-19T13:38:48+00:00">Fri, 08/19/2016 - 09:38</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/kendall-square-location-choice-for-bayer-and-crispr-therapeutics-upstart" data-a2a-title="Bayer, CRISPR Therapeutics JV to start at Kendall Square location "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fkendall-square-location-choice-for-bayer-and-crispr-therapeutics-upstart&amp;title=Bayer%2C%20CRISPR%20Therapeutics%20JV%20to%20start%20at%20Kendall%20Square%20location%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Fri, 19 Aug 2016 13:38:48 +0000 badams 456331 at http://www.fiercebiotech.com Woodford-backed Cambridge U fund raises $98M for tech & life sciences http://www.fiercebiotech.com/biotech/woodford-backed-cambridge-u-fund-raises-98m-for-tech-life-sciences <span property="schema:name">Woodford-backed Cambridge U fund raises $98M for tech &amp; life sciences</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-19T12:28:22+00:00">Fri, 08/19/2016 - 08:28</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/woodford-backed-cambridge-u-fund-raises-98m-for-tech-life-sciences" data-a2a-title="Woodford-backed Cambridge U fund raises $98M for tech &amp; life sciences"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fwoodford-backed-cambridge-u-fund-raises-98m-for-tech-life-sciences&amp;title=Woodford-backed%20Cambridge%20U%20fund%20raises%20%2498M%20for%20tech%20%26amp%3B%20life%20sciences"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Fri, 19 Aug 2016 12:28:22 +0000 badams 456251 at http://www.fiercebiotech.com Cerulean is blue as it cuts half of staffers after cancer trial failure http://www.fiercebiotech.com/biotech/cerulean-blue-as-it-cuts-half-staffers-after-kidney-cancer-trial-failure <span property="schema:name">Cerulean is blue as it cuts half of staffers after cancer trial failure</span> <span rel="schema:author"><span lang="" about="/user/40596" typeof="schema:Person" property="schema:name" datatype="">badams</span></span> <span property="schema:dateCreated" content="2016-08-19T10:18:48+00:00">Fri, 08/19/2016 - 06:18</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/cerulean-blue-as-it-cuts-half-staffers-after-kidney-cancer-trial-failure" data-a2a-title="Cerulean is blue as it cuts half of staffers after cancer trial failure"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fcerulean-blue-as-it-cuts-half-staffers-after-kidney-cancer-trial-failure&amp;title=Cerulean%20is%20blue%20as%20it%20cuts%20half%20of%20staffers%20after%20cancer%20trial%20failure"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Fri, 19 Aug 2016 10:18:48 +0000 badams 456221 at http://www.fiercebiotech.com Chutes & Ladders: Google's Calico snags Daphne Koller from Coursera http://www.fiercebiotech.com/biotech/chutes-ladders-google-s-calico-snags-daphne-koller-from-coursera <span property="schema:name">Chutes &amp; Ladders: Google&#039;s Calico snags Daphne Koller from Coursera</span> <span rel="schema:author"><span lang="" about="/user/40141" typeof="schema:Person" property="schema:name" datatype="">ahuntley</span></span> <span property="schema:dateCreated" content="2016-08-18T19:03:05+00:00">Thu, 08/18/2016 - 15:03</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/chutes-ladders-google-s-calico-snags-daphne-koller-from-coursera" data-a2a-title="Chutes &amp; Ladders: Google&#039;s Calico snags Daphne Koller from Coursera"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fchutes-ladders-google-s-calico-snags-daphne-koller-from-coursera&amp;title=Chutes%20%26amp%3B%20Ladders%3A%20Google%26%23039%3Bs%20Calico%20snags%20Daphne%20Koller%20from%20Coursera"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Thu, 18 Aug 2016 19:03:05 +0000 ahuntley 456211 at http://www.fiercebiotech.com Israeli startup Nutrinia nabs $30M to back pivotal trials of oral insulin for infants http://www.fiercebiotech.com/biotech/israeli-startup-nutrinia-nabs-30m-to-back-pivotal-trials-oral-insulin-for-infants <span property="schema:name">Israeli startup Nutrinia nabs $30M to back pivotal trials of oral insulin for infants</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-18T16:50:54+00:00">Thu, 08/18/2016 - 12:50</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/israeli-startup-nutrinia-nabs-30m-to-back-pivotal-trials-oral-insulin-for-infants" data-a2a-title="Israeli startup Nutrinia nabs $30M to back pivotal trials of oral insulin for infants"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fisraeli-startup-nutrinia-nabs-30m-to-back-pivotal-trials-oral-insulin-for-infants&amp;title=Israeli%20startup%20Nutrinia%20nabs%20%2430M%20to%20back%20pivotal%20trials%20of%20oral%20insulin%20for%20infants"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Thu, 18 Aug 2016 16:50:54 +0000 slawrence 456166 at http://www.fiercebiotech.com Nordic Nanovector wraps up enrollment in pre-dosed arms of NHL trial http://www.fiercebiotech.com/biotech/nordic-nanovector-wraps-up-enrollment-pre-dosed-arms-nhl-trial <span property="schema:name">Nordic Nanovector wraps up enrollment in pre-dosed arms of NHL trial </span> <span rel="schema:author"><span lang="" about="/user/39341" typeof="schema:Person" property="schema:name" datatype="">ntaylor</span></span> <span property="schema:dateCreated" content="2016-08-18T16:00:31+00:00">Thu, 08/18/2016 - 12:00</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/nordic-nanovector-wraps-up-enrollment-pre-dosed-arms-nhl-trial" data-a2a-title="Nordic Nanovector wraps up enrollment in pre-dosed arms of NHL trial "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fnordic-nanovector-wraps-up-enrollment-pre-dosed-arms-nhl-trial&amp;title=Nordic%20Nanovector%20wraps%20up%20enrollment%20in%20pre-dosed%20arms%20of%20NHL%20trial%20"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Thu, 18 Aug 2016 16:00:31 +0000 ntaylor 456156 at http://www.fiercebiotech.com Caribou claims CRISPR-Cas9 advance on DNA repair http://www.fiercebiotech.com/biotech/caribou-claims-crispr-cas9-advance-dna-repair <span property="schema:name">Caribou claims CRISPR-Cas9 advance on DNA repair</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-18T15:49:16+00:00">Thu, 08/18/2016 - 11:49</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/caribou-claims-crispr-cas9-advance-dna-repair" data-a2a-title="Caribou claims CRISPR-Cas9 advance on DNA repair"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fcaribou-claims-crispr-cas9-advance-dna-repair&amp;title=Caribou%20claims%20CRISPR-Cas9%20advance%20on%20DNA%20repair"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Thu, 18 Aug 2016 15:49:16 +0000 slawrence 456141 at http://www.fiercebiotech.com FDA rejects Portola’s lead candidate, pushing shares down http://www.fiercebiotech.com/biotech/fda-rejects-portola-s-lead-candidate-pushing-shares-down <span property="schema:name">FDA rejects Portola’s lead candidate, pushing shares down</span> <span rel="schema:author"><span lang="" about="/user/40136" typeof="schema:Person" property="schema:name" datatype="">slawrence</span></span> <span property="schema:dateCreated" content="2016-08-18T14:10:09+00:00">Thu, 08/18/2016 - 10:10</span> <span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="http://www.fiercebiotech.com/biotech/fda-rejects-portola-s-lead-candidate-pushing-shares-down" data-a2a-title="FDA rejects Portola’s lead candidate, pushing shares down"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Ffda-rejects-portola-s-lead-candidate-pushing-shares-down&amp;title=FDA%20rejects%20Portola%E2%80%99s%20lead%20candidate%2C%20pushing%20shares%20down"></a><a class="a2a_button_facebook"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_email"></a> <a class="a2a_button_print"></a></span> Thu, 18 Aug 2016 14:10:09 +0000 slawrence 456091 at http://www.fiercebiotech.com